PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
about
Strategies for early detection of resectable pancreatic cancerVarious diffusion magnetic resonance imaging techniques for pancreatic cancerManagement of borderline resectable pancreatic cancerImaging preoperatively for pancreatic adenocarcinomaUtility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancerComputer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging.Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.Borderline resectable pancreatic cancer: definitions and management.Pancreatic adenocarcinomaDiagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.Meta-analysis of quantitative diffusion-weighted MR imaging in differentiating benign and malignant pancreatic masses.Surgery for pancreatic carcinoma: state of the art.Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature.Metabolic Activity by 18F-FDG-PET/CT Is Prognostic for Stage I and II Pancreatic CancerThe clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patientsPET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.Imaging of pancreatic ductal adenocarcinoma: State of the art.Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?Role of endoscopic ultrasound in pancreatic cancer.Pancreatic involvement by plasma cell neoplasms.Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature.Endoscopic ultrasound in the diagnosis of pancreatic cancer.Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients.Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review.Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.The role of imaging in the clinical practice of radiation oncology for pancreatic cancer.The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma.[Ductal adenocarcinoma and unusual differential diagnosis].
P2860
Q24564006-912059C7-D4EF-4499-A05F-E3A795256983Q26769804-62BED921-F21C-4DA6-BB20-B28F9A0A535DQ26781445-7CBA6474-CA2D-4A37-97BB-62F9FE6CBCB6Q26799450-3A5198D9-48EE-4A7A-A65A-023BE35FAD10Q26827392-59811E6C-8920-4A9D-B3FE-B66DAB6AD393Q33758556-808A6A28-B9BB-4BD6-9100-878F52D39414Q33854598-45E823C8-3525-43DF-BDCF-EE29B19B2FDBQ34067852-49A436D0-A34A-43D2-AF71-83FF383B64DCQ34140498-CE9D196A-B11B-47F0-831E-E3949D70CA9DQ34194318-BD0DFC66-FF11-4CD9-A0A4-11BCE99B0F34Q34551574-C8619CBC-5453-4CF8-B6A3-1A93BA3C9200Q34846267-B8B95007-BB98-4AA4-BEBD-4F480667BD48Q34901401-4FD79EDC-557B-4F52-9B1F-2D4D05E5A6F6Q35495731-2ADD9F61-201C-484B-85E5-F0A21E639D6DQ35675141-873E040B-FCDC-438A-A365-FFBD7B292447Q35944817-32B95C2F-08D4-45F9-937E-2A066485EC65Q36288743-76D0D3D4-AB17-4076-BBE1-7C9150425608Q36540475-27B00D9E-AE81-4346-BB5E-B6930CFBB190Q36570306-B93C49FE-A47A-48CF-8BBE-08AF63842EC7Q36745224-6A3E601D-AD1F-45F9-8C88-6E508C3AC1D3Q36832133-D62B62BD-5C06-4069-9928-B6971308FD22Q37305985-728CD879-A8BB-4E8C-9520-40B181225597Q37480860-E719FB79-78C3-4BA3-BA28-B277F2D7F998Q37503384-01257097-F7E2-40B8-B843-F1F81206F53CQ37918442-219F56CB-9AAA-4A32-AE52-6E31E4F5B30AQ37968594-6F789055-68D0-4323-BC86-47AC59C3BC1FQ37991239-A1972F14-9060-44C9-8983-685395FA6DC5Q38073684-A1AD5E26-D584-41CF-ACED-42A9430A7A39Q38093243-E9564EA2-7E0A-401B-AD83-0D487DFE9B1DQ38955039-F33FA35A-A182-41A4-8998-F9FB74208920Q42318810-F70284BB-CE25-4AFA-B89E-41B9825328F4Q42698235-5AA13537-381D-4066-A5D3-C1A0E4A51BEDQ46644415-F49B3624-A88F-4277-B403-AE695093121CQ46876969-E7C77C1A-9914-48B9-998F-097588E49D41Q47163065-D08ED2DB-86F9-428F-B4D6-90C3FAAB938AQ48156217-D6EA4520-B808-42E2-A59E-3003F9F52EF1Q48190547-211B783D-6B72-4E70-ACC2-E185DA9E7A04Q48354898-3CF7B34A-DD01-414B-BAD3-61CD2B1755D7Q49391836-3A80A0E9-9695-426B-9993-2CC1D8BB57E2Q52984214-B7EE8AD4-BCD4-46C8-93A9-7C17096289FF
P2860
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@ast
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@en
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@nl
type
label
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@ast
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@en
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@nl
prefLabel
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@ast
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@en
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@nl
P2093
P1476
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
@en
P2093
Alfredo A Santillan
Daly Belinc
Dung-Tsa Chen
Edward A Eikman
Janet Walters
Jeffrey M Farma
Marcovalerio Melis
Mokenge Malafa
P2888
P304
P356
10.1245/S10434-008-9992-0
P577
2008-06-13T00:00:00Z
P5875
P6179
1008543477